ArticleBMC cancer2025

Adaptive cohort design and LAT1 expression scale: study protocol for a Phase 2a trial of QBS72S in breast cancer brain metastases.

Rukayat Taiwo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.